Evidence map›Paper›PMID 34596289›Full record

ArticleJournal of neuroendocrinology2021

The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability.

Eleonora Lauricella, Mauro Cives, Alessandra Bracigliano, Ottavia Clemente, Valentina Felici, Rossella Lippolis, Brunella Amoruso, Eleonora Pelle', Barbara Mandriani, Chiara Esposto and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Eleonora LauricellaDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Mauro CivesDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Alessandra BraciglianoIstituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples, Italy.
Ottavia ClementeIstituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples, Italy.
Valentina FeliciDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Rossella LippolisDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Brunella AmorusoDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Eleonora Pelle'Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Barbara MandrianiDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Chiara EspostoDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Cira ForteIstituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples, Italy.
Francesco PerriIstituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples, Italy.
Camillo PortaDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Salvatore TafutoIstituto Nazionale Tumori, IRCCS Fondazione "G. Pascale", Naples, Italy.
University of Bari Aldo Moro · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITIstituto Tumori Bari · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 23583Associazione per la Ricerca Biomolecolare Onlus, Acquaviva, Italy 2020
6 · The paper itself

Abstract

The COVID-19 pandemic has added another layer of complexity to the fears of patients with neuroendocrine tumors (NETs). Little is known regarding the psychological impact of the COVID-19 outbreak on patients with gastroenteropancreatic or bronchopulmonary (BP) NETs. We longitudinally surveyed the mental symptoms and concerns of NET patients during the plateau phase of the first (W1) and second epidemic waves (W2) in Italy. Seven specific constructs (depression, anxiety, stress, health-related quality of life, NET-related quality of life, patient-physician relationship, psychological distress) were investigated using validated screening instruments, including DASS-21, EORTC QLQ-C30, EORTC QLQ GI.NET21, PDRQ9 and IES-R. We enrolled 197 patients (98 males) with a median age of 62 years. The majority of the patients had G1/G2 neoplasms. Some 38% of the patients were on active treatment. At W1, the prevalence of depression, anxiety and stress was 32%, 36% and 26% respectively. The frequency of depression and anxiety increased to 38% and 41% at W2, whereas no modifications were recorded in the frequency of stress. Poor educational status was associated with higher levels of anxiety at both W1 (odds ratio [OR] = 1.33 ± 0.22; p = .07) and W2 (OR = 1.45 ± 0.26; p = .03). Notably, post-traumatic stress symptoms were observed in the 58% of the patients, and both single marital status (OR = 0.16, 95% confidence interval [CI] = 0.06-0.48; p = .0009) and low levels of formal education (OR = 0.47, 95% CI = 0.23-0.99; p = .05) predicted their occurrence. No significant deteriorations of health-related quality of life domains were observed from W1 to W2. High patient care satisfaction was documented despite the changes in health systems resource allocation. NET patients have an increased risk of developing post-traumatic stress symptoms as result of the COVID-19 pandemic. Specific screening measures and psychological interventions should be implemented in NET clinics to prevent, recognize and treat mental distress in this vulnerable population.

Indexed as

anxietycarcinoiddepressionHRQoLpost-traumatic stress disorder

Identifiers

PMID34596289
PMCPMC8646700
OpenAlexW3200468158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.